MENU
+Compare
BMEA
Stock ticker: NASDAQ
AS OF
Jun 13, 11:11 AM (EDT)
Price
$2.54
Change
-$0.07 (-2.68%)
Capitalization
93.93M

BMEA Biomea Fusion Forecast, Technical & Fundamental Analysis

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more

BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMEA with price predictions
Jun 12, 2025

BMEA in upward trend: 10-day moving average broke above 50-day moving average on June 06, 2025

The 10-day moving average for BMEA crossed bullishly above the 50-day moving average on June 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 29, 2025. You may want to consider a long position or call options on BMEA as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BMEA just turned positive on May 29, 2025. Looking at past instances where BMEA's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

BMEA moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMEA advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BMEA moved out of overbought territory on June 05, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMEA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BMEA broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BMEA entered a downward trend on June 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.413) is normal, around the industry mean (16.792). P/E Ratio (0.000) is within average values for comparable stocks, (59.920). BMEA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.337). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (258.227).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMEA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMEA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BMEA is expected to report earnings to fall 30.96% to -55 cents per share on August 04

Biomea Fusion BMEA Stock Earnings Reports
Q2'25
Est.
$-0.55
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.05
The last earnings report on May 05 showed earnings per share of -80 cents, beating the estimate of -91 cents. With 177.47K shares outstanding, the current market capitalization sits at 93.93M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOIVF6.180.15
+2.40%
Bollore Investissement
ANZGY19.580.16
+0.81%
ANZ GROUP HLDGS LTD
UMICY3.350.02
+0.67%
Umicore SA
FTCO3.06N/A
-0.08%
Fortitude Gold Corporation
GMBL0.24-0.06
-20.00%
Esports Entertainment Group, Inc.

BMEA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with ARCT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+4.40%
ARCT - BMEA
51%
Loosely correlated
+1.61%
CCCC - BMEA
35%
Loosely correlated
+6.58%
PRME - BMEA
34%
Loosely correlated
-4.58%
IDYA - BMEA
34%
Loosely correlated
+1.64%
CRBU - BMEA
32%
Poorly correlated
-1.69%
More